Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Prodinger

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Infection|January 1, 1994
Hepatitis A in Western Austria--the epidemiological situation before the introduction of active immunisationW M Prodinger, C Larcher, B M Sölder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1997
A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cellsM G Schwendinger, M Spruth, J Schoch, et al.
The Biochemical Journal|May 16, 1998
The C-terminus of factor H: monoclonal antibodies inhibit heparin binding and identify epitopes common to factor H and factor H-related proteinsW M Prodinger, J Hellwage, M Spruth, et al.
Journal of Clinical Microbiology|May 4, 2012
Improvement of detection of bacterial pathogens in normally sterile body sites with a focus on orthopedic samples by use of a commercial 16S rRNA broad-range PCR and sequence analysisK Grif, I Heller, W M Prodinger, et al.
Immunology Letters|May 1, 1995
Reduced CD21 (CR2) and CD54 (ICAM-1) expression in MT2 cells with HIV-1 or HIV-2 strainsC Larcher, N Julen, W M Prodinger, et al.
Infection and Immunity|April 1, 1993
Isolation and biochemical characterization of the iC3b receptor of Candida albicansS Alaei, C Larcher, C Ebenbichler, et al.
International Journal of Antimicrobial Agents|August 26, 1998
Study of beta-lactam resistance in ceftazidime-resistant clinical isolates of EnterobacteriaceaeH Bujdáková, A Lausová, S Jankovicová, et al.
Clinical and Experimental Immunology|August 1, 1993
Determination of soluble CD21 as a parameter of B cell activationH P Huemer, C Larcher, W M Prodinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 1998
Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21)W M Prodinger, M G Schwendinger, J Schoch, et al.
Immunobiology|October 25, 2000
B cell-mediated infection of stimulated and unstimulated autologous T lymphocytes with HIV-1: role of complementS Doepper, H Stoiber, L Kacani, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Infection|January 1, 1994
Hepatitis A in Western Austria--the epidemiological situation before the introduction of active immunisationW M Prodinger, C Larcher, B M Sölder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1997
A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cellsM G Schwendinger, M Spruth, J Schoch, et al.
The Biochemical Journal|May 16, 1998
The C-terminus of factor H: monoclonal antibodies inhibit heparin binding and identify epitopes common to factor H and factor H-related proteinsW M Prodinger, J Hellwage, M Spruth, et al.
Journal of Clinical Microbiology|May 4, 2012
Improvement of detection of bacterial pathogens in normally sterile body sites with a focus on orthopedic samples by use of a commercial 16S rRNA broad-range PCR and sequence analysisK Grif, I Heller, W M Prodinger, et al.
Immunology Letters|May 1, 1995
Reduced CD21 (CR2) and CD54 (ICAM-1) expression in MT2 cells with HIV-1 or HIV-2 strainsC Larcher, N Julen, W M Prodinger, et al.
Infection and Immunity|April 1, 1993
Isolation and biochemical characterization of the iC3b receptor of Candida albicansS Alaei, C Larcher, C Ebenbichler, et al.
International Journal of Antimicrobial Agents|August 26, 1998
Study of beta-lactam resistance in ceftazidime-resistant clinical isolates of EnterobacteriaceaeH Bujdáková, A Lausová, S Jankovicová, et al.
Clinical and Experimental Immunology|August 1, 1993
Determination of soluble CD21 as a parameter of B cell activationH P Huemer, C Larcher, W M Prodinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 1998
Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21)W M Prodinger, M G Schwendinger, J Schoch, et al.
Immunobiology|October 25, 2000
B cell-mediated infection of stimulated and unstimulated autologous T lymphocytes with HIV-1: role of complementS Doepper, H Stoiber, L Kacani, et al.
Pageof 4